Polymorphic miRNA‐mediated gene contribution to inhibitor development in haemophilia A
- 6 June 2012
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 18 (6) , 1003-1007
Abstract
Summary: Development of inhibitory antibodies is perhaps the most serious complication of FVIII replacement therapy, precluding efficient clinical management of patients with haemophilia A (HA). The development and function of immune system are also regulated by microRNAs (miRNAs). Mutations and changes in the level of expression of some miRNA genes have been associated with the onset and progression of immunological disorders. The aim of this study was to investigate new genetic polymorphisms in loci for miRNA and their targets to evaluate whether these SNPs may confer susceptibility to inhibitor development in patients with HA. Italian HA patients with and without inhibitors and healthy controls were recruited in this study. For SNP analysis, standard DNA sequencing method was used. We have studied four SNPs, i.e. rs36101366, rs34683807, rs1803603 and rs3024496 located in the 3′UTR of F8 and IL‐10 genes. These SNPs have been checked for their frequencies in patients with and without inhibitors, but no statistically significant differences were found. Then, we have searched for other genetic variants in loci for haematopoietic‐specific miRNAs, i.e. hsa‐mir‐150, hsa‐mir‐155, hsa‐mir‐146a, hsa‐mir‐142, hsa‐mir‐181a and in a specific miRNA, hsa‐mir‐1184, i.e. predicted to be located in the intron 22 of F8 gene. For all miRNAs selected, we did not identify any sequence variation in our study population. This is the first study to demonstrate that there was no association between selected SNPs in miRNAs and their targets and the susceptibility to inhibitor development in people affected by HA.Keywords
This publication has 30 references indexed in Scilit:
- A MicroRNA-regulated and GP64-pseudotyped Lentiviral Vector Mediates Stable Expression of FVIII in a Murine Model of Hemophilia AMolecular Therapy, 2011
- MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseasesTranslational Research, 2011
- Impact of polymorphisms of the major histocompatibility complex class II, interleukin‐10, tumor necrosis factor‐α and cytotoxic T‐lymphocyte antigen‐4 genes on inhibitor development in severe hemophilia AJournal of Thrombosis and Haemostasis, 2009
- Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebratesNucleic Acids Research, 2009
- MicroRNA target site polymorphisms and human diseaseTrends in Genetics, 2008
- miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurelyProceedings of the National Academy of Sciences, 2007
- PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traitsNucleic Acids Research, 2006
- NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responsesProceedings of the National Academy of Sciences of the United States of America, 2006
- Ribo-gnome: The Big World of Small RNAsScience, 2005
- The functions of animal microRNAsNature, 2004